» Articles » PMID: 9205122

Molecular Cloning of a Novel Vascular Endothelial Growth Factor, VEGF-D

Overview
Journal Genomics
Specialty Genetics
Date 1997 Jun 15
PMID 9205122
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

We have identified and characterized a novel vascular endothelial growth factor (VEGF), VEGF-D, which is structurally related to vascular endothelial growth factor C. A full-length cDNA for human VEGF-D was cloned following the identification of an EST obtained through a TFASTA search of public EST databases. The murine VEGF-D was subsequently isolated from a mouse lung cDNA library. The human VEGF-D gene was mapped to human chromosome Xp22.31. Both human and mouse VEGF-D are strongly expressed in lung and encode the eight cysteine residues that are highly conserved among the members of this family. The high level of conservation between mouse and human VEGF-D may emphasize the biological importance of this gene. Recently the murine gene, FIGF, which is identical to mouse VEGF-D, was reported.

Citing Articles

Tumor angiogenesis and anti-angiogenic therapy.

Guo Z, Jing X, Sun X, Sun S, Yang Y, Cao Y Chin Med J (Engl). 2024; 137(17):2043-2051.

PMID: 39051171 PMC: 11374217. DOI: 10.1097/CM9.0000000000003231.


Vascular Endothelial Growth Factor-D (VEGF-D): An Angiogenesis Bypass in Malignant Tumors.

Bokhari S, Hamar P Int J Mol Sci. 2023; 24(17).

PMID: 37686121 PMC: 10487419. DOI: 10.3390/ijms241713317.


Pathological angiogenesis: mechanisms and therapeutic strategies.

Dudley A, Griffioen A Angiogenesis. 2023; 26(3):313-347.

PMID: 37060495 PMC: 10105163. DOI: 10.1007/s10456-023-09876-7.


Tumor Vasculature as an Emerging Pharmacological Target to Promote Anti-Tumor Immunity.

Tzeng H, Huang Y Int J Mol Sci. 2023; 24(5).

PMID: 36901858 PMC: 10002465. DOI: 10.3390/ijms24054422.


Advancements in Cancer Immunotherapies.

Roy R, Singh S, Misra S Vaccines (Basel). 2023; 11(1).

PMID: 36679904 PMC: 9861770. DOI: 10.3390/vaccines11010059.